Bioorganic and medicinal chemistry letters p. 2847 - 2850 (2001)
Update date:2022-08-02
Topics:
Lavoie
Bouchain
Frechette
Woo
Abou-Khalil
Leit
Fournel
Yan
Trachy-Bourget
Beaulieu
Li
Besterman
Delorme
Histone deacetylase inhibitors (HDACs) have emerged as a novel class of antiproliferative agents. Utilizing structure-based design, the synthesis of a series of sulfonamide hydroxamic acids is described. Further optimization of this series by substitution of the terminal aromatic ring yielded HDAC inhibitors with good in vitro and in vivo activities.
View MoreContact:0571-
Address:zhejing
Hangzhou Ocean Chemical Co., Ltd.
website:http://www.hzoceanchem.com
Contact:+86-571-88025872, 28272092, 28272096
Address:Room 623 ,Building No 1 , COFCO Radius Commercial Center Xiwen Road, Xiacheng District, Hangzhou, Zhejiang Province, China
Beijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Tianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Shanghai Taibao Pharmaceutical Technology Co., Ltd(expird)
Contact:021-52217366
Address:shanghai
Doi:10.1002/anie.200352919
(2004)Doi:10.1016/S0040-4020(01)82309-7
(1991)Doi:10.1016/j.ica.2003.09.019
(2004)Doi:10.1016/j.tetlet.2004.01.058
(2004)Doi:10.1021/jo026236y
(2002)Doi:10.1002/anie.201306643
(2013)